A more recent study by Prensner and colleagues, however, refutes that PCGEM1 and PRNCR1 interact with the androgen receptor and that either gene is a component of androgen receptor signaling or is involved in castration-resistant prostate cancer [106]. This evidence concerns the gene PCGEM1 and prostate cancer.